TIME IN RANGE IS A VALUABLE INDICATOR OF GLYCEMIC CONTROL AND PATIENT RISK
Time in range is a valuable predictor of patient risk and outcomes⁴
- $1.6B estimated annual costs for hypoglycemia-related hospitalizations in the US.⁵
- Time in range is strongly associated with lower risk of complications.⁶
- A TIR of 70% and 50% corresponded with an average A1C of approximately 7% and 8%, respectively.⁷
Eversense patients achieve a median 63% time in range8
The advanced sensor technology and under-the-skin placement help patients reach unprecedented levels of wear time, leading to improved clinical outcomes.